Aktie A2PGPL GUIDED THERAPEUTICS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Guided Therapeutics, Inc.

Aktien

A2PGPL

US40171F5017

GTHP

Markt geschlossen - OTC Markets
Andere Börsenplätze
 16:03:01 23.05.2024 		% 5 Tage % 1. Jan.
0,109 USD +35,40 % Intraday Chart für Guided Therapeutics, Inc. +21,11 % -28,99 %
14.05. Guided Therapeutics, Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
28.03. Guided Therapeutics, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K)
Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation
Guided Therapeutics, Inc. Announces CEO Changes
Guided Therapeutics, Inc. Announces Executive Changes
GUIDED THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PGPL Aktie
  4. Nachrichten Guided Therapeutics, Inc.
  5. Andere Sprachen